Calpis' AmealPeptide lowers blood pressure in 2 placebo-controlled trials
The milk-derived dietary supplement AmealPeptide has been shown to significantly reduce daytime ambulatory systolic blood pressure by 3.6 mmHg and 24-hr systolic blood pressure by 6.2 mmHg in two placebo-controlled trials, confirming its safety and efficacy for patients with Stage I and Stage II hypertension.